[
    [
        {
            "time": "2018",
            "orginal_text": "一图读财报：安图生物2018年营收同比增长37.82%",
            "features": {
                "keywords": [
                    "安图生物",
                    "2018年",
                    "营收",
                    "同比增长",
                    "37.82%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "一图读财报：安图生物2018年营收同比增长37.82%",
            "scores": {
                "News_content": "一图读财报：安图生物2018年营收同比增长37.82%",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018",
            "orginal_text": "安图生物：2018年净利润5.63亿元 拟10派8元",
            "features": {
                "keywords": [
                    "安图生物",
                    "2018年",
                    "净利润",
                    "5.63亿元",
                    "拟10派8元"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "安图生物：2018年净利润5.63亿元 拟10派8元",
            "scores": {
                "News_content": "安图生物：2018年净利润5.63亿元 拟10派8元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018",
            "orginal_text": "安图生物(603658.SH)2018年净利润升25.98%至5.63亿元 拟10派8元",
            "features": {
                "keywords": [
                    "安图生物",
                    "603658.SH",
                    "2018年",
                    "净利润",
                    "升25.98%",
                    "5.63亿元",
                    "拟10派8元"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "安图生物(603658.SH)2018年净利润升25.98%至5.63亿元 拟10派8元",
            "scores": {
                "News_content": "安图生物(603658.SH)2018年净利润升25.98%至5.63亿元 拟10派8元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018",
            "orginal_text": "安图生物：为全资子公司提供担保不超3亿元 大额借贷担保",
            "features": {
                "keywords": [
                    "安图生物",
                    "全资子公司",
                    "担保",
                    "3亿元",
                    "大额借贷"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "安图生物：为全资子公司提供担保不超3亿元 大额借贷担保",
            "scores": {
                "News_content": "安图生物：为全资子公司提供担保不超3亿元 大额借贷担保",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018",
            "orginal_text": "安图生物：2018年净利润同比增25.98%，拟10派8元",
            "features": {
                "keywords": [
                    "安图生物",
                    "2018年",
                    "净利润",
                    "同比增25.98%",
                    "拟10派8元"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "安图生物：2018年净利润同比增25.98%，拟10派8元",
            "scores": {
                "News_content": "安图生物：2018年净利润同比增25.98%，拟10派8元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "近期",
            "orginal_text": "医药行业周报: 首批科创板受理企业出台, 创新投资主线明晰",
            "features": {
                "keywords": [
                    "医药行业",
                    "科创板",
                    "受理企业",
                    "创新投资"
                ],
                "sentiment_score": 0.75,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "科技创新"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "医药行业周报: 首批科创板受理企业出台, 创新投资主线明晰",
            "scores": {
                "News_content": "医药行业周报: 首批科创板受理企业出台, 创新投资主线明晰",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        }
    ]
]